Amryt Pharma Plc ADR (AMYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,000 | -104,527 | -62,998 | -30,487 | N/A |
| Depreciation Amortization | 55,162 | 72,082 | 19,754 | 367 | N/A |
| Income taxes - deferred | -9,268 | -535 | -934 | N/A | N/A |
| Accounts receivable | -3,543 | -7,685 | -4,732 | -532 | N/A |
| Accounts payable and accrued liabilities | 11,758 | 8,909 | -6,337 | 3,051 | N/A |
| Other Working Capital | -7,842 | -4,391 | -11,858 | 1,438 | N/A |
| Other Operating Activity | -31,727 | 63,038 | 29,633 | 10,709 | 0 |
| Operating Cash Flow | $15,540 | $26,891 | $-37,472 | $-15,454 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -729 | -1,503 | -578 | -80 | N/A |
| Net Acquisitions | 107,942 | N/A | 24,985 | N/A | N/A |
| Purchase Sale Intangibles | -816 | -963 | -74 | -155 | N/A |
| Other Investing Activity | -811 | -876 | 18 | -149 | 0 |
| Investing Cash Flow | $106,402 | $-2,379 | $24,425 | $-229 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 31,176 | 5,914 | N/A |
| Debt Repayment | -116,629 | N/A | -21,990 | N/A | N/A |
| Common Stock Issued | 4,701 | 37,927 | 63,009 | N/A | N/A |
| Other Financing Activity | -13,498 | -11,899 | -6,253 | -2,649 | 0 |
| Financing Cash Flow | $-125,426 | $26,028 | $65,942 | $3,265 | $N/A |
| Exchange Rate Effect | -2,282 | 1,029 | 3,108 | -767 | N/A |
| Beginning Cash Position | 118,798 | 67,229 | 11,226 | 24,411 | N/A |
| End Cash Position | 113,032 | 118,798 | 67,229 | 11,226 | N/A |
| Net Cash Flow | $-5,766 | $51,569 | $56,003 | $-13,185 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 15,540 | 26,891 | -37,472 | -15,454 | N/A |
| Capital Expenditure | -729 | -1,503 | -578 | -80 | N/A |
| Free Cash Flow | 14,811 | 25,388 | -38,050 | -15,534 | 0 |